American International Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-60,087
| Closed | -$958K | – | 623 |
|
|
2024
Q1 | $958K | Buy |
60,087
+5,463
| +10% | +$82.3K | ﹤0.01% | 1324 |
|
|
2023
Q4 | $918K | Sell |
54,624
-457
| -0.8% | -$6.25K | ﹤0.01% | 1342 |
|
|
2023
Q3 | $644K | Buy |
55,081
+3,249
| +6% | +$43.5K | ﹤0.01% | 1459 |
|
|
2023
Q2 | $697K | Sell |
51,832
-1,052
| -2% | -$15.1K | ﹤0.01% | 1450 |
|
|
2023
Q1 | $877K | Buy |
52,884
+245
| +0.5% | +$4.04K | 0.01% | 1288 |
|
|
2022
Q4 | $979K | Buy |
52,639
+245
| +0.5% | +$3.77K | 0.01% | 1218 |
|
|
2022
Q3 | $672K | Buy |
52,394
+7,548
| +17% | +$89.5K | ﹤0.01% | 1398 |
|
|
2022
Q2 | $314K | Sell |
44,846
-3,362
| -7% | -$24.7K | ﹤0.01% | 1881 |
|
|
2022
Q1 | $400K | Sell |
48,208
-3,394
| -7% | -$24K | ﹤0.01% | 1851 |
|
|
2021
Q4 | $349K | Sell |
51,602
-1,543
| -3% | -$10.1K | ﹤0.01% | 2035 |
|
|
2021
Q3 | $282K | Sell |
53,145
-1,264
| -2% | -$6.91K | ﹤0.01% | 2219 |
|
|
2021
Q2 | $313 | Sell |
54,409
-2,161
| -4% | -$11.2K | ﹤0.01% | 2228 |
|
|
2021
Q1 | $261 | Buy |
56,570
+150
| +0.3% | +$596 | ﹤0.01% | 2219 |
|
|
2020
Q4 | $188 | Sell |
56,420
-1,619
| -3% | -$5.44K | ﹤0.01% | 2313 |
|
|
2020
Q3 | $172K | Sell |
58,039
-1,319
| -2% | -$5.16K | ﹤0.01% | 2222 |
|
|
2020
Q2 | $274K | Buy |
59,358
+2,253
| +4% | +$10.1K | ﹤0.01% | 1942 |
|
|
2020
Q1 | $220K | Sell |
57,105
-3,300
| -5% | -$13.5K | ﹤0.01% | 1857 |
|
|
2019
Q4 | $227K | Sell |
60,405
-507
| -0.8% | -$2.37K | ﹤0.01% | 2141 |
|
|
2019
Q3 | $323K | Sell |
60,912
-425
| -0.7% | -$2.26K | ﹤0.01% | 1896 |
|
|
2019
Q2 | $236K | Sell |
61,337
-172
| -0.3% | -$743 | ﹤0.01% | 2124 |
|
|
2019
Q1 | $314K | Sell |
61,509
-1,994
| -3% | -$5.86K | ﹤0.01% | 1965 |
|
|
2018
Q4 | $122K | Sell |
63,503
-488
| -0.8% | -$1.4K | ﹤0.01% | 2486 |
|
|
2018
Q3 | $242K | Buy |
63,991
+1,153
| +2% | +$3.61K | ﹤0.01% | 2316 |
|
|
2018
Q2 | $196K | Buy |
62,838
+6,903
| +12% | +$20.9K | ﹤0.01% | 2357 |
|
|
2018
Q1 | $134K | Buy |
55,935
+7,742
| +16% | +$25.7K | ﹤0.01% | 2495 |
|
|
2017
Q4 | $188K | Buy |
48,193
+228
| +0.5% | +$753 | ﹤0.01% | 2354 |
|
|
2017
Q3 | $121K | Buy |
47,965
+3,586
| +8% | +$9.84K | ﹤0.01% | 2554 |
|
|
2017
Q2 | $122K | Buy |
+44,379
| New | +$92.6K | ﹤0.01% | 2598 |
|
|
2016
Q2 | – | Sell |
-44,119
| Closed | -$52K | – | 3267 |
|
|
2016
Q1 | $52K | Hold |
44,119
| – | – | ﹤0.01% | 3862 |
|
|
2015
Q4 | $108K | Sell |
44,119
-77
| -0.2% | -$221 | ﹤0.01% | 3425 |
|
|
2015
Q3 | $133K | Buy |
44,196
+52
| +0.1% | +$224 | ﹤0.01% | 3198 |
|
|
2015
Q2 | $182K | Buy |
+44,144
| New | +$176K | ﹤0.01% | 3101 |
|
|
2014
Q3 | – | Sell |
-2,000
| Closed | -$5.06K | – | 5013 |
|
|
2014
Q2 | $5.06K | Hold |
2,000
| – | – | ﹤0.01% | 4646 |
|
|
2014
Q1 | $4.52K | Buy |
+2,000
| New | +$4.18K | ﹤0.01% | 4563 |
|
Other funds holding CPRX
DM
American International Group's CPRX Position: Q2 2024 in Review
American International Group sold out of Catalyst Pharmaceutical (CPRX) in Q2 2024, closing a stake of 60,087 shares — an estimated $958K sold.
American International Group first reported a position in CPRX in Q1 2014 and held it in 34 quarters. The position peaked at $979K in Q4 2022. 271 funds tracked by Wall St. Rank hold CPRX as of Q2 2024.
- American International Group reported no remaining Catalyst Pharmaceutical position as of Q2 2024 after selling out during the quarter.
- American International Group sold 60,087 Catalyst Pharmaceutical shares in Q2 2024, an estimated $958K.
- American International Group first reported a position in Catalyst Pharmaceutical in Q1 2014 and held it in 34 quarters.
- American International Group's Catalyst Pharmaceutical position peaked at $979K in Q4 2022.
- 271 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.